Literature DB >> 32753011

Engineering of Nanospheres Dispersed Microneedle System for Antihypertensive Action.

Mrunmayi Sardesai1, Pravin Shende1.   

Abstract

BACKGROUND: A combinational therapy is mostly preferred in hypertension treatment because of low-dose and less side effects like pretibial edema, and gastrointestinal bleeding.
OBJECTIVE: So the objective of the present work was to formulate an advanced drug delivery system in the form of bio-responsive microneedles by incorporating nifedipine, a cardiodepressant and diltiazem, a vasodilator for effective synergism in the treatment of hypertension.
METHODS: The pH-responsive PLGA nanospheres of diltiazem were formulated using Water-in-Oil-in- Water (W/O/W) double emulsion and solvent-diffusion-evaporation technique. These nanospheres were added to nifedipine-PVP mixture and then incorporated into mold to develop microneedles.
RESULTS: The microneedles showed the release of nifedipine almost 96.93± 2.31% for 24 h due to high PVP solubilization. The nanospheres of diltiazem on contact with acidic pH of skin managed to form of CO2 bubbles and increase the internal pressure to burst PLGA shell due to pore formation. The mean blood pressure observed for the normal group was 89.58 ± 3.603 mmHg, whereas the treatment with the new formulation significantly reduced the mean blood pressure up to 84.11 ± 2.98 mmHg in comparison to the disease control group (109.9 ± 1.825 mm Hg).
CONCLUSION: This system co-delivers the drugs nifedipine and diltiazem in hypertension and shows an advance alternative approach over conventional drug delivery system. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Hypertension; diltiazem; microneedles; nanospheres; nifedipine; vasodilator

Mesh:

Substances:

Year:  2020        PMID: 32753011     DOI: 10.2174/1567201817666200804110003

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  3 in total

1.  Microneedle-mediated therapy for cardiovascular diseases.

Authors:  Ruyi Zhou; Jicheng Yu; Zhen Gu; Yuqi Zhang
Journal:  Drug Deliv Transl Res       Date:  2021-10-12       Impact factor: 4.617

2.  Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug Release.

Authors:  He Lv; Shiri Guo; Gaoyi Zhang; Wanli He; Yonghui Wu; Deng-Guang Yu
Journal:  Polymers (Basel)       Date:  2021-12-07       Impact factor: 4.329

3.  The Effect of Drug Heterogeneous Distributions within Core-Sheath Nanostructures on Its Sustained Release Profiles.

Authors:  Haixia Xu; Xizi Xu; Siyu Li; Wen-Liang Song; Deng-Guang Yu; S W Annie Bligh
Journal:  Biomolecules       Date:  2021-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.